Inhalation Vaccines

The Exciting Potential of Inhalation Vaccines

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Cannabinoids

Kindeva and BOL Pharma Using Low Global Warming Potential (GWP) Propellant in Development of Inhaled Cannabinoid Products

Kindeva Drug Deliver

Respiratory Diseases

Developing a Novel Anti-Inflammatory for Patients with Severe Asthma

Robert Clarke, Ph.D

Kinaset Therapeutics

Inhalation

Integrating Development and Manufacturing Experience with Inhalation Solutions

Recipharm

Inhalation

Supporting Inhalation Development for Both Drugs and Devices

Vectura Group

Inhalation Design

The Future of Inhalation

Vectura Group

Formulation

Developing and Characterizing DPI Formulations for Biologics

Eunice Costa; Constança Cacela

Hovione

Inhalation

FDA Approves First Inhaler with Built-in Sensors

Emilie Branch

Pharma's Almanac

Inhalation

GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD

Emilie Branch

Pharma's Almanac

Inhalation

Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol

TEVA

Clinical Trials

COPD Patients Excited about AstraZeneca Trial Results

Guy Tiene

Nice Insight

Inhalation

Hovione strengthens Inhalation Services portfolio

Hovione

Formulation

Polyphor AG: Polyphor Launches the Development of an Inhaled Formulation of its Antibiotic Murepavadin

Polyphor

Clinical Trials

AstraZeneca, Pieris Pharmaceuticals Join Forces to Combat Respiratory Diseases

Cynthia A. Challener, Ph.D.

Pharma's Almanac